The 81 references in paper A. Smirnov V., O. Nesterova B., R. Golubev V., А. Смирнов В., О. Нестерова Б., Р. Голубев В. (2014) “Янтарная кислота и ее применение в медицине. Часть I. Янтарная кислота: метаболит и регулятор метаболизма организма человека // Succinic acid and its application in medicine. Part I. Succinic acid: metabolite and regulator of metabolism of the human body” / spz:neicon:nefr:y:2014:i:2:p:33-41

1
Ariza AC, Deen PMT, Robben JH. The succinate receptor as a novel therapeutic target for oxidative and metabolic stressrelated conditions. Front Endocrinol (Lausanne) 2012; 3(22): 1-8
(check this in PDF content)
2
Kushnir MM, Komaromy-Hiller G, Shushan B et al. Analysis of dicarboxylic acids by tandem mass spectrometry. HighРис. 3. Прирост объемной скорости кровотока в сосудах кожи в пробе с ацетилхолином в зависимости от стадии хронической болезни почек (НИИ нефрологии ПСПбГМУ им. акад. И.П. Павлова) throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin Chem 2001; 47(11): 1993-2002
(check this in PDF content)
3
Теличкин ИА. Роберт Кох (1843-1910). Клин Мед 1996; (1): 78-79
(check this in PDF content)
4
Афанасьев ВВ. Клиническая фармакология реамберина (очерк). Полисан, СПб., 2005; 39 с
(check this in PDF content)
5
Андреева НН. Экспериментальные и клинические аспекты применения мексидола при гипоксии. Мед альманах 2009; 4(9): 193-197
(check this in PDF content)
6
Мейес П. Цикл лимонной кислоты: катаболизм ацетилСоА. В: Марри Р, Греннер Д, Мейес П, Родуэлл В. Биохимия человека. Мир, М., 2009; Т.1: 72-180
(check this in PDF content)
7
Наточин ЮВ. Ионорегулирующая функция почки. Наука, Л., 1976; 99-108
(check this in PDF content)
8
Krebs HA, Eggleston LV, D’Alessandro A. The effect of succinate and amytal on the reduction of acetoacetate in animal tissues. Biochem J 1961; 79: 537-549
(check this in PDF content)
9
Chance B, Hollunger G. The interaction of energy and electron transfer reactions in mitochondria: 1. General properties and nature of the products of succinate-linked reduction of pyridine nucleotide. J Biol Chem 1961; 236(5): 1534-1543
(check this in PDF content)
10
Мейес П. Окислительное фосфорилирование и транспортные системы митохондрий. В: Марри Р, Греннер Д, Мейес П, Родуэлл В. Биохимия человека, в 2-х т.т. Мир, М., 2009; Т.1: 127-139
(check this in PDF content)
11
Hawkins BJ, Levin MD, Doonan PJ et al. Mitochodrial complex II prevents hypoxic but not calcium- and proapoptotic Bcl-2 protein-induced mitochondrial membrane potential loss. J Biol Chem 2010; 285(34): 26494-26505
(check this in PDF content)
12
Писаренко ОИ, Хлопков ВН, Рууге ЭК. Изучение методом ЯМР образования сукцината из экзогенных предшественников в неаэрируемых митохондриях сердца крысы. Биохимия 1986; 51(4): 1174 – 1179
(check this in PDF content)
13
Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54(6): 1615-1625
(check this in PDF content)
14
Weinberg JM, Venkatahalam MA, Roeser NE, Nissim I. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc Natl Acad Sci USA 2000; 97: 2826-2831
(check this in PDF content)
15
Hearl WG, Churchich JE. A mitochondrial NADP+-dependent reductase related to the 4-aminobutyrate shunt. J Biol Chem 1985; 260(30): 16361-16366
(check this in PDF content)
16
Cairns CB, Ferroggiaro AA, Walther JM et al. Postishemic administration of succinate reverses the impairment of oxidative phosphorylation after cardiac ischemia and reperfusion injury. Circulation 1997; 96(Suppl.9): 260-265
(check this in PDF content)
17
Маевский ЕИ, Гришина ЕВ, Окон МС и др. Сравнительная оценка энергетического вклада анаэробного образования сукцината из различных субстратов в митохондриях печени. Янтарная кислота в медицине, пищевой промышленности, сельском хозяйстве Пущино, ОНТИ ГШЦ РАИ, 1997; 42-51
(check this in PDF content)
18
Хочачка П, Сомеро Дж. Биохимическая адаптация. Мир, М., 1988; 568 с
(check this in PDF content)
19
Taegtmeyer H. Metabolic responses to cardiac hypoxia. Increased production of succinate by rabbit papillary muscles. Circ Res 1978; 43(5): 808-815
(check this in PDF content)
20
Маевский ЕИ, Гришина ЕВ, Розенфельд АС и др. Анаэробное образование сукцината и облегчение его окисления – возможные механизмы адаптации клетки к кислородному голоданию. Биомед журнал 2000; 1: 32-36
(check this in PDF content)
21
Mohan C, Geiger PJ, Bessman SP. The intracellular site of action of insulin: the mitochondrial Krebs cycle. Curr Top Cell Regul 1989; 30: 105-142
(check this in PDF content)
22
Lohse MJ, Krasel C, Winstel R, Mayor F. G-protein-coupled receptor kinases. Kidney Int 1996; 49(4): 1047-1052
(check this in PDF content)
23
Aguiar CJ, Andrade VL, Gomes ER et al. Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKAdependent pathway. Cell Calcium 2010; 47(1): 37-46
(check this in PDF content)
24
Gullans SR, Kone BC, Avison MJ, Giebisch G. Succinate alters respiration, membrane potential, and intracellular K+ in proximal tubule. Am J Physiol 1988; 255(6, Pt.2): F1170-1177
(check this in PDF content)
25
He W, Miao FJ, Lin DC et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004; 429(6988): 188-193
(check this in PDF content)
26
Correa P, Kruglov E, Thompson M et al. Succinate is a paracrine signal for liver damage. J Hepatol 2007; 47(2): 262-269
(check this in PDF content)
27
Peti-Peterdi J, Kang JJ, Toma I. Activation of the reninangiotensin system in diabetes – new concepts. Nephrol Dial Transplant 2008; 23(10): 3047-3049
(check this in PDF content)
28
Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell 2008; 135(3): 561-571
(check this in PDF content)
29
Toma I, Kang JJ, Sipos A et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 2008; 118(7): 2526-2534
(check this in PDF content)
30
Robben JH, Fenton RA, Vargas SL et al. Localisation of the succinate receptor in the distal nephron and its signaling in polarised MDCK cells. Kidney Int 2009; 76(12): 1258-1267
(check this in PDF content)
31
Vargas SL, Toma I, Kahg JJ et al. Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J Am Soc Nephrol 2009; 20(5): 1002-1011
(check this in PDF content)
32
Pajor AM. Molecular properties of sodium/dicarboxylate cotransporters. J Membr Biol 2000; 175(1): 1-8
(check this in PDF content)
33
Kekuda R, Wang H, Huang W et al. Primary structure and functional characteristics of a mammalian sodium-coupled high affinity dicarboxylate transporter. J Biol Chem 1999; 274(6):
(check this in PDF content)
34
2-3429 34. Camara AK, Lesnefsky EJ, Stowe DF. Potential therapeutic benefits of strategies directed to mitochondria. Antioxid Redox Signal 2010; 13(3): 279-347
(check this in PDF content)
35
Fosslien E. Mitochondrial medicine – molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 2001; 31(1): 25-67
(check this in PDF content)
36
Archer SL. Mitochondrial dynamics – mitochondrial fission and fusion in human diseases. N Engl J Med 2013; 369(23): 2236-2251
(check this in PDF content)
37
Granata S, Zaza G, Simone S et al. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 2009; doi: 10.1186/1471-2164-10-388
(check this in PDF content)
38
Tamaki M, Miyashita K, Wakino S et al. Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase. Kidney Int 2013; doi: 10.1038/ki.2013.473
(check this in PDF content)
39
Raj DS, Boivin MA, Dominic EA et al. Haemodialysis induces mitochondrial dysfunction and apoptosis. Eur J Clin Invest 2007; 37(12): 971-977
(check this in PDF content)
40
Antignani A, Youle RJ. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane ? Curr Opin Cell Biol 2006; 18(6): 685-689
(check this in PDF content)
41
Dejean LM, Martinez-Caballero S, Kinnally KW. Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis? Cell Death Differ 2006; 13(8): 1387-1395
(check this in PDF content)
42
Holmuhamedov E, Lemasters JJ. Ethanol exposure decreases mitochondrial outer membrane permeability in cultured rat hepatocytes. Arch Biochem Biophys 2009; 481(2): 226-233
(check this in PDF content)
43
Ершова СА. Дисфункция митохондрий при нефропатиях у детей. Нефрология и диализ 2003; 5(4): 344-353
(check this in PDF content)
44
Oguro H, Iijima K, Takahashi K et al. Successful treatment with succinate in a patient with MELAS. Int Med 2004; 43(5): 427-431
(check this in PDF content)
45
Захаров ВВ, Федоров АВ, Чухрова МГ. Купирование алкогольного абстинентного синдрома и прерывание запоев с применением препаратов янтарной кислоты. Вестник СПбМА им. И.И.Мечникова 2004; (2): 116-118
(check this in PDF content)
46
Ливанов ГА, Куценко СА, Батоцыренов БВ и др. Коррекция свободнорадикальных процессов препаратом янтарной кислоты (реамберином) в интенсивной терапии острых отравлений. Анестезиол и реаниматол 2001; (4): 28-31
(check this in PDF content)
47
Silacci P, Hayoz D. Oxidative stress as the triggering event for vascular remodelling. Nephrol Dial Transplant 1998; 13(6): 1343-1346
(check this in PDF content)
48
Kuroki M, Voest EE, Amano S et al. Reactive oxygen species intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996; 98(7): 1667-1675
(check this in PDF content)
49
Tsurumi Y, Murohara T, Krasinski K et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997; 3(8): 879-886
(check this in PDF content)
50
Locatelli F, Canaud B, Eckardt K-U et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18(7): 1272-1280
(check this in PDF content)
51
Тугушева ФА, Зубина ИМ, Митрофанова ОВ. Оксидативный стресс и хроническая болезнь почек. Нефрология 2007; 11(3): 29-47
(check this in PDF content)
52
Смирнов АВ, Добронравов ВА, Каюков ИГ. Кардиоренальный континуум: патогенетические основы превентивной нефрологии. Нефрология 2005; 9(3): 7-15
(check this in PDF content)
53
Тугушева ФА, Зубина ИМ. Оксидативный стресс и его участие в неиммунных механизмах прогрессирования хронической болезни почек. Нефрология 2007; 13(3): 42-48
(check this in PDF content)
54
Massy ZA, Nguyen-Кhoa T. Oxidative stress and chronic renal failure: markers and management. J Nephrol 2002; 15(4): 336-341
(check this in PDF content)
55
Epperlein MM, Nourooz-Zadeh J, Jayasena SD et al. Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 1998; 9(3): 457-463
(check this in PDF content)
56
Ozden M, Maral H, Akaydin D et al. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem 2002; 35(4): 269-273
(check this in PDF content)
57
Westhuyzen J, Adams CE, Fleming SJ. Evidence for oxidative stress during in vitro dialysis. Nephron 1995; 70(1): 49-54
(check this in PDF content)
58
Galle J. Oxidative stress in chronic renal failure. Nephrol Dial Transplant 2001; 16(11): 2135-2137
(check this in PDF content)
59
Hoenich NA. Platelet and leucocytes behaviour during hemodialysis. Contrib Nephrol 1999; (125): 120-132
(check this in PDF content)
60
Haag-Weber M, Horl WH. Dysfunction of polymorphonuclear leucocytes in uremia. Semin Nephrol 1996; 16(3): 192-201
(check this in PDF content)
61
Смирнов АВ, Васильев АН, Костерева ЕМ и др. Опыт применения препарата «Реамберин» и его влияние на показатели крови пациентов, получающих лечение программным гемодиализом. Нефрология и диализ 2007; 9(3): 290
(check this in PDF content)
62
Daschner M, Lenhartz H, Botticher D et al. Influence of dialysis on plasma lipid peroxidation products and antioxidants levels. Kidney Int 1996; 50(4): 1268-1272
(check this in PDF content)
63
Ross EA, Koo LC, Moberly JB. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1997; 30(4): 489-494
(check this in PDF content)
64
Bayes B, Pastor MC, Bonal J et al. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis – role of seniority and intravenous ferrotherapy: analysis at 4 year follow-up. Nephrol Dial Transplant 2006; 21(4): 984-990
(check this in PDF content)
65
Hоrl WH. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 2002; 13(Suppl.1): S62-71
(check this in PDF content)
66
Lucchi L, Bergamini S, Botti B et al. Influence of different hemodialysis membranes on red blood cell susceptibility to oxidative stress. Artif Organs 2000; 24(1): 1-6
(check this in PDF content)
67
Mune M, Yukawa S, Kishino M et al. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int 1999; 56(Suppl 71): S126-129
(check this in PDF content)
68
Tsuruoka S, Kawaguchi A, Nishiki K et al. Vitamin E-bonded hemodialyser improves neutrophil function ahd oxidative stress in patients with end-stage renal failure. Am J Kidney Dis 2002; 39(1): 127-133
(check this in PDF content)
69
Меншутина МА. Сравнительная оценка реактивности сосудов как формы дисфункции эндотелия у больных атеросклерозом и хронической болезнью почек. Нефрология 2004; 8(3): 56-61
(check this in PDF content)
70
Смирнов АВ, Петрищев НН, Панина ИЮ и др. Скорость клубочковой фильтрации – показатель функционального состояния эндотелия на ранних стадиях развития хронической болезни почек. Тер арх 2007; 79(6): 25-29
(check this in PDF content)
71
Miyazaki H, Matsuoka H, Itabe H et al. Hemodialysis impairs endothelial function via oxidative stress. Effects of vitamin E-coated dialyser. Circulation 2000; 101(9): 1002-1006
(check this in PDF content)
72
Stewart T, Jung FF, Manning J, Vehascari VM. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension. Kidney Int 2005; 68(5): 2180-2188
(check this in PDF content)
73
Tepel M. Oxidative stress: does it play a role in the genesis of essential hypertension and hypertension of uremia. Nephrol Dial Transplant 2003; 18(8): 1439-1442
(check this in PDF content)
74
Borawski J, Pawlak K, Naumnik B, Mysliwiec M. Relations between oxidative stress, hepatocyte growth factor, and liver disease in hemodialysis patients. Ren Fail 2002; 24(6): 825-837
(check this in PDF content)
75
Белоусов ЮБ, ред. Современный подход к цитопротекторной терапии. Методическое пособие для врачей. М., 2010; 30 с
(check this in PDF content)
76
Голиков АП, Бойцов СА, Михин ВП, Полумисков ВЮ. Свободно-радикальное окисление и сердечно-сосудистая патология: коррекция антиоксидантами. Леч врач 2003; (4): 34-47
(check this in PDF content)
77
Василев СЦ, Сафонов АБ. Роль янтарной кислоты в терапии митохондриальных болезней у детей. Педиатрия 2000; (2): 88-90
(check this in PDF content)
78
Розенфельд АС, Маевский ЕИ. Теоретикометодологические аспекты действия сукцината при спортивных нагрузках и гипоксии. Изд-во ГОУ ВПО « Рос. гос. проф.-пед. ун-т», Екатеринбург, 2007; 174 с
(check this in PDF content)
79
Saravanan R, Pari L. Succinic acid monoethyl ester, a novel insulinotropic agent: effect on lipid composition and lipid peroxidation in streptozotocin-nicotinamide induced type 2 diabetic rats. Mol Cell Biochem 2007; 296(1-2): 165-176
(check this in PDF content)
80
Tretter L, Szabados G, Ando A, Horvath I. Effect of succinate on mitochondrial lipid peroxidation. 2. The protective effect of succinate against functional and structural changes induced by lipid peroxidation. J Bioenerg Biomembr 1987; 19(1): 31-44
(check this in PDF content)
81
Романцов МГ, Коваленко АЛ, ред. Реамберин в клинической практике. Полисан, СПб., 2007; 6-45 Авторы заявляют об отсутствии конфликта интересов. Поступила в редакцию: 01.12.2013 г.
(check this in PDF content)